PREGRAVIDAR COUNSELING IN THE CONTEXT OF PRIMARY HEALTH CARE



Cite item

Full Text

Abstract

PreGRAVIDAR counseling is an important stage of preparation for pregnancy, aimed at improving women's reproductive health and increasing the chances of a successful pregnancy. The article discusses in detail the key aspects that need to be discussed with a primary care physician before conception. These include plans for the birth of children, current health status, including chronic illnesses and medication, as well as mental health and genetic status. An important element of pre-pregnancy training is a timely medical examination, which allows you to identify and correct possible risks for the unborn child. Special attention is paid to the need to manage chronic diseases such as diabetes mellitus and epilepsy before pregnancy. The importance of psychological support and genetic counseling is also emphasized in order to minimize risks and prevent possible complications. In addition, the article addresses prevention issues, including infection screening, vaccination, and lifestyle changes, such as combating obesity and quitting bad habits. All these measures are aimed at creating the most favorable conditions for conception and further development of pregnancy. Thus, pre-pregnancy counseling plays a critical role in maintaining women's reproductive health and ensuring the safety of expectant mothers and their children.

Full Text

Restricted Access

References

  1. Dobrokhotova IuÉ, Dzhokhadze LS. Preconception care as a real way to improve the perinatal outcomes. Russian Journal of Human Reproduction. 2019;25(6):38‑43. (In Russ.) doi: 10.17116/repro20192506138
  2. Podilyakina Yu.S., Kulov D.V., Amirbekova Zh.T. Pregravidary preparation. Research and Practical Medicine Journal. 2021;8(2):83-89. (In Russ.) doi: 10.17709/2410-1893-2021-8-2-8
  3. Dorney E, Boyle JA, Walker R, et al. A Systematic Review of Clinical Guidelines for Preconception Care. Semin Reprod Med. 2022;40(3-04):157-169. doi: 10.1055/s-0042-1748190.
  4. Stupak VS, Sokolovskaya TA, Postoev VA. Morbidity among parturient and postpartum women in the federal districts and constituent entities of the Russian Federation. Russian Journal of Preventive Medicine. 2021;24(9):17‑23. (In Russ.)
  5. doi: 10.17116/profmed20212409117
  6. Filippov OS, Guseva EV. Maternal mortality in the Russian Federation in 2020: the first year of the pandemic. Russian Journal of Human Reproduction. 2022;28(1):8‑28. (In Russ.)
  7. doi: 10.17116/repro2022280118
  8. Lassi ZS, Imam AM, Dean SV, Bhutta ZA. Preconception care: preventing and treating infections. Reprod Health. 2014;11(3):S4. doi: 10.1186/1742-4755-11-S3-S4.
  9. Hussein N, Kai J, Qureshi N. The effects of preconception interventions on improving reproductive health and pregnancy outcomes in primary care: A systematic review. Eur J Gen Pract. 2016;22(1):42-52. doi: 10.3109/13814788.2015.1099039.
  10. Bastani F, Hashemi S, Bastani N, Haghani H. Impact of preconception health education on health locus of control and self-efficacy in women. East Mediterr Health J. 2010;16(4):396-401.
  11. Hillemeier MM, Downs DS, Feinberg ME, et al. Improving women's preconceptional health: findings from a randomized trial of the Strong Healthy Women intervention in the Central Pennsylvania women's health study. Womens Health Issues. 2008;18(6):S87-96. doi: 10.1016/j.whi.2008.07.008.
  12. Dude AM, Schueler K, Schumm LP, et al. Preconception care and severe maternal morbidity in the United States. Am J Obstet Gynecol MFM. 2022;4(2):100549. doi: 10.1016/j.ajogmf.2021.100549.
  13. Milovanov AP, Dobriakov AV. The increasing importance of extragenital pathology in the structure of maternal mortality in Russia. Russian Journal of Archive of Pathology. 2018;80(2):3‑6. (In Russ.) doi: 10.17116/patol20188023-6
  14. Bello JK, Rao G, Stulberg DB. Trends in contraceptive and preconception care in United States ambulatory practices. Fam Med. 2015;47(4):264-71
  15. Hayes DK, Fan AZ, Smith RA, Bombard JM. Trends in selected chronic conditions and behavioral risk factors among women of reproductive age, behavioral risk factor surveillance system, 2001-2009. Prev Chronic Dis. 2011;8(6):A120
  16. Shishcanu D., Marianian A.Y., Iliadi-Tulbure C. Preconceptional care: opportunities and challenges. Acta Biomedica Scientifica. 2018;3(3):69-74. (In Russ.) doi: 10.29413/ABS.2018-3.3.10
  17. Murphy M, McHugh S, O'Keeffe LM, et al. Preventive health counselling during antenatal care using the pregnancy risk assessment monitoring system (PRAMS) in Ireland. BMC Pregnancy Childbirth. 2020;20(1):98. doi: 10.1186/s12884-020-2756-y.
  18. Cheng D, Schwarz EB, Douglas E, Horon I. Unintended pregnancy and associated maternal preconception, prenatal and postpartum behaviors. Contraception. 2009;79(3):194-8. doi: 10.1016/j.contraception.2008.09.009
  19. Bantyeva M.N. THE ABORTION PROBLEM SITUATION IN RUSSIA IN 2008-2015 YEARS. Obstetrics, Gynecology and Reproduction. 2016;10(3):47-52. (In Russ.) doi: 10.17749/2313-7347.2016.10.2.047-052
  20. Preconception Care (Position Paper). https:/ /www.aafp.org/about/policies/all/preconcepti on-care.html
  21. Allen D, Hunter MS, Wood S, Beeson T. One Key Question®: First Things First in Reproductive Health. Matern Child Health J. 2017;21(3):387-392. doi: 10.1007/s10995-017-2283-2.
  22. Envision SRH PATH Questions. Envisionsrh. https://www.envisionsrh.com/path-framework
  23. Zakharova T.G. Contraception as the main method of family planning in the work of a family doctor. Zemskiy doktor. 2015; 3 (27): 5-11 (In Russ).
  24. Ni W, Gao X, Su X, et al. Birth spacing and risk of adverse pregnancy and birth outcomes: A systematic review and dose-response meta-analysis. Acta Obstet Gynecol Scand. 2023;102(12):1618-1633. doi: 10.1111/aogs.14648.
  25. Hanley GE, Hutcheon JA, Kinniburgh BA, Lee L. Interpregnancy Interval and Adverse Pregnancy Outcomes: An Analysis of Successive Pregnancies. Obstet Gynecol. 2017;129(3):408-415. doi: 10.1097/AOG.0000000000001891.
  26. Schummers L, Hutcheon JA, Hernandez-Diaz S, et al. Association of Short Interpregnancy Interval With Pregnancy Outcomes According to Maternal Age. JAMA Intern Med. 2018;178(12):1661-1670. doi: 10.1001/jamainternmed.2018.4696.
  27. Mukhamadieva S.M., Olimova F.A., Rustamova M.S., Pulatova A.P. Medical and social aspects of reproductive health of women with disabilities with disabilities of the musculoskeletal system. Medical Bulletin of the National Academy of Sciences of Tajikistan. 2020; 10 (33): 62-70 (In Russ.).
  28. König-Bachmann M, Zenzmaier C, Schildberger B. Health professionals' views on maternity care for women with physical disabilities: a qualitative study. BMC Health Serv Res. 2019;19(1):551. doi: 10.1186/s12913-019-4380-y.
  29. Iezzoni LI, Mitra M. Transcending the counter-normative: Sexual and reproductive health and persons with disability. Disabil Health J. 201710(3):369-370. doi: 10.1016/j.dhjo.2017.04.001.
  30. Sibirskaya EV, Blinnikova ES. Diabetes mellitus and pregnancy (literature review). Russian Journal of Human Reproduction. 2020;26(6):122‑130. (In Russ.) doi: 10.17116/repro202026061122
  31. Chen X, Zhang Y, Chen H, et al. Association Between Serum Glycated Hemoglobin Levels at Early Gestation and the Risk of Subsequent Pregnancy Loss in Pregnant Women Without Diabetes Mellitus: Prospective Cohort Study. JMIR Public Health Surveill. 2023;9:e46986. doi: 10.2196/46986
  32. Xiong W, Han L, Tang X, et al. Preconception Blood Pressure and Adverse Pregnancy Outcomes: A Population-Based Cohort Study. Hypertension. 2024;81(4):e31-e40. doi: 10.1161/HYPERTENSIONAHA.123.22296.
  33. Ziganshin AM, Kulavskiĭ VA, Vashkevich AG. Pregnancy and epilepsy. Russian Bulletin of Obstetrician-Gynecologist. 2019;19(3):43‑48. (In Russ.) doi: 10.17116/rosakush20191903143
  34. Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse Pregnancy Outcomes and Cardiovascular Disease Risk: Unique Opportunities for Cardiovascular Disease Prevention in Women: A Scientific Statement From the American Heart Association. Circulation. 2021;143(18):e902-e916. doi: 10.1161/CIR.0000000000000961.
  35. Chighizola CB, Clowse M, Meroni PL, et al. The SPROUT study: A survey on current management practice of reproductive aspects in women of childbearing age with systemic autoimmune rheumatic diseases. Autoimmun Rev. 2023;22(8):103376. doi: 10.1016/j.autrev.2023.103376
  36. Verbiest S, Cené C, Chambers E, et al. Listening to patients: Opportunities to improve reproductive wellness for women with chronic conditions. Health Serv Res. 2022;57(6):1396-1407. doi: 10.1111/1475-6773.14082
  37. Steel A, Lucke J, Adams J. The prevalence and nature of the use of preconception services by women with chronic health conditions: an integrative review. BMC Womens Health. 2015;15:14. doi: 10.1186/s12905-015-0165-6.
  38. Goossens J, De Roose M, Van Hecke A, Goemaes R, Verhaeghe S, Beeckman D. Barriers and facilitators to the provision of preconception care by healthcare providers: A systematic review. Int J Nurs Stud. 2018;87:113-130. doi: 10.1016/j.ijnurstu.2018.06.009.
  39. Birru Talabi M, Callegari LS, Kazmerski TM, et al. A blueprint for a new model of sexual and reproductive health care in subspecialty medicine. Health Serv Res. 2023;58(1):216-222. doi: 10.1111/1475-6773.14074.
  40. Hassan A, Yates L, Hing AK, et al. Dobbs and disability: Implications of abortion restrictions for people with chronic health conditions. Health Serv Res. 2023;58(1):197-201. doi: 10.1111/1475-6773.14108.
  41. Evstifeeva S.E., Shalnova S.A., Kutsenko V.A., et al. Anxiety and depression: ten-year changes of prevalence and its association with demographic and socio-economic characteristics according to the ESSE-RF study. Cardiovascular Therapy and Prevention. 2023;22(8S):3796. (In Russ.) doi: 10.15829/1728-8800-2023-3796.
  42. Ozcan NK, Boyacıoğlu NE, Enginkaya S, et al. Reproductive health in women with serious mental illnesses. J Clin Nurs. 2014;23(9-10):1283-91. doi: 10.1111/jocn.12332.
  43. Nicholson WK, Setse R, Hill-Briggs F, et al. Depressive symptoms and health-related quality of life in early pregnancy. Obstet Gynecol. 2006;107(4):798-806. doi: 10.1097/01.AOG.0000204190.96352.05.
  44. Miller ES, Saade GR, Simhan HN, et al. Trajectories of antenatal depression and adverse pregnancy outcomes. Am J Obstet Gynecol. 2022;226(1):108.e1-108.e9. doi: 10.1016/j.ajog.2021.07.007.
  45. Thiele GA, Ryan DM, Oberlander TF, Hanley GE. Preconception mental health and the relationship between antenatal depression or anxiety and gestational diabetes mellitus: a population-based cohort study. BMC Pregnancy Childbirth. 2022;22(1):670. doi: 10.1186/s12884-022-05002-5.
  46. Packer CH, Pilliod RA, Chatroux LR, et al. Increased rates of adverse perinatal outcomes in women with gestational diabetes and depression. J Matern Fetal Neonatal Med. 2021;34(23):3862-3866. doi: 10.1080/14767058.2019.1701647.
  47. Perova E.I., Stenyaeva N.N., Apolikhina I.A. Pregnancy on the background of anxiety-depressive states. Obstetrics and gynecology. 2013; (6).
  48. Stein A, Pearson RM, Goodman SH, et al. Effects of perinatal mental disorders on the fetus and child. Lancet. 2014;384(9956):1800-19. doi: 10.1016/S0140-6736(14)61277-0.
  49. US Preventive Services Task Force; Barry MJ, Nicholson WK, et al. Screening for Anxiety Disorders in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(24):2163-2170. doi: 10.1001/jama.2023.9301
  50. O'Connor EA, Henninger ML, Perdue LA, et al. Anxiety Screening: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2023;329(24):2171-2184. doi: 10.1001/jama.2023.6369.
  51. US Preventive Services Task Force; Barry MJ, Nicholson WK, et al. Screening for Depression and Suicide Risk in Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;329(23):2057-2067. doi: 10.1001/jama.2023.9297.
  52. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.
  53. Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092-7. doi: 10.1001/archinte.166.10.1092
  54. Levis B, Sun Y, He C, et al. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA. 2020;323(22):2290-2300. doi: 10.1001/jama.2020.6504.
  55. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284-92. doi: 10.1097/01.MLR.0000093487.78664.3C.
  56. Anderson KN, Lind JN, Simeone RM, et al. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects. JAMA Psychiatry. 2020;77(12):1246-1255. doi: 10.1001/jamapsychiatry.2020.2453
  57. Gao SY, Wu QJ, Sun C, et al. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births. BMC Med. 2018;16(1):205. doi: 10.1186/s12916-018-1193-5.
  58. US Preventive Services Task Force; Curry SJ, Krist AH, et al. Screening and Behavioral Counseling Interventions to Reduce Unhealthy Alcohol Use in Adolescents and Adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2018;320(18):1899-1909. doi: 10.1001/jama.2018.16789.
  59. Patnode CD, Perdue LA, Rushkin M, et al. Screening for Unhealthy Drug Use: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2020;323(22):2310-2328. doi: 10.1001/jama.2019.21381.
  60. Klimkiewicz A, Jakubczyk A, Mach A, et al. Psychometric properties of the polish version of the Alcohol Use Disorders Identification Test (AUDIT). Drug Alcohol Depend. 2021;218:108427. doi: 10.1016/j.drugalcdep.2020.108427
  61. Sokol RJ, Martier SS, Ager JW. The T-ACE questions: practical prenatal detection of risk-drinking. Am J Obstet Gynecol. 1989;160(4):863-8; discussion 868-70. doi: 10.1016/0002-9378(89)90302-5.
  62. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;131(10):1121-3. doi: 10.1176/ajp.131.10.1121.
  63. Fedorova SS. Characteristics of substance use disorders among women. S.S. Korsakov Journal of Neurology and Psychiatry. 2014;114(5‑2):15‑20. (In Russ.).
  64. Ryan KS, Prewitt KC, Hayer S, et al. Opioid Use in Pregnancy: A Review. Obstet Gynecol Surv. 2023;78(1):35-49. doi: 10.1097/OGX.0000000000001094.
  65. Jones HE, Martin PR, Heil SH, et al. Treatment of opioid-dependent pregnant women: clinical and research issues. J Subst Abuse Treat. 2008;35(3):245-59. doi: 10.1016/j.jsat.2007.10.007
  66. Siddiqi AD, Chen TA, Britton M, et al. Changes in Substance Use Treatment Providers' Delivery of the 5A's for Non-Cigarette Tobacco Use in the Context of a Comprehensive Tobacco-Free Workplace Program Implementation. Int J Environ Res Public Health. 2023;20(3):2730. doi: 10.3390/ijerph20032730
  67. Havard A, Chandran JJ, Oei JL. Tobacco use during pregnancy. Addiction. 2022;117(6):1801-1810. doi: 10.1111/add.15792.
  68. Fanshawe TR, Halliwell W, Lindson N, et al. Tobacco cessation interventions for young people. Cochrane Database Syst Rev. 2017;11(11):CD003289. doi: 10.1002/14651858.CD003289.pub6.
  69. US Preventive Services Task Force; Krist AH, Davidson KW, et al. Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(3):265-279. doi: 10.1001/jama.2020.25019.
  70. Committee Opinion No. 691: Carrier Screening for Genetic Conditions. Obstet Gynecol. 2017;129(3):e41-e55. doi: 10.1097/AOG.0000000000001952.
  71. Frigon MP, Lavoie M, Emond MJ, et al. Family planning decisional needs assessment for recessive hereditary disorders: Insights from carrier couples and professionals. Patient Educ Couns. 2022;105(7):2537-2545. doi: 10.1016/j.pec.2021.11.027.
  72. Pivazyan LG, Unanyan AL, Davydova JuD, Poymanova OF, Bondarenko EN, Ishchenko AI. Cervical cancer prevention and screening: a review of international clinical guidelines. Russian Journal of Human Reproduction. 2022;28(5):90‑99. (In Russ.) https://doi.org/10.17116/repro20222805190
  73. Kolyadina, I. V., Poddubnaya, I. V., & Komov, D. V. (2015). Breast cancer screening: world experience and prospects. Russian Journal Of Oncology, 20(1), 42-46. (In Russ,) doi: 10.17816/onco40145
  74. ACOG Committee Opinion No. 762: Prepregnancy Counseling. Obstet Gynecol. 2019;133(1):e78-e89. doi: 10.1097/AOG.0000000000003013.
  75. Namazova-Baranova L.S., Fedoseenko M.V., Selimzyanova L.R., et al. Modern Approaches in Immunoprophylaxis of Infectious Diseases During Pregnancy. Pediatric pharmacology. 2022;19(5):417-423. (In Russ.) doi: 10.15690/pf.v19i5.2487
  76. CDC. Guidelines for Vaccinating Pregnant Persons. Pregnancy and Vaccination, July. 18, 2024. https://www.cdc.gov/vaccines-pregnancy/hcp/vaccination-guidelines/index.html
  77. Batyukova V.E. Domestic violence. problems and solutions. Zakon I pravo. 2021; (1): 83-85. (In Russ.). doi: 10.24412/2073-3313-2021-1-83-85
  78. Miller E, Decker MR, McCauley HL, et al.. Pregnancy coercion, intimate partner violence and unintended pregnancy. Contraception. 2010;81(4):316-22. doi: 10.1016/j.contraception.2009.12.004.
  79. US Preventive Services Task Force; Curry SJ, Krist AH, et al. Screening for Intimate Partner Violence, Elder Abuse, and Abuse of Vulnerable Adults: US Preventive Services Task Force Final Recommendation Statement. JAMA. 2018;320(16):1678-1687. doi: 10.1001/jama.2018.14741.
  80. Rabin RF, Jennings JM, Campbell JC, Bair-Merritt MH. Intimate partner violence screening tools: a systematic review. Am J Prev Med. 2009;36(5):439-445.e4. doi: 10.1016/j.amepre.2009.01.024.
  81. Davis M, Padilla-Medina DM. Brief Intimate Partner Violence Perpetration Screening Tools: A Scoping Review. Trauma Violence Abuse. 2021;22(4):900-913. doi: 10.1177/1524838019888545.
  82. Andreeva E.N., Sheremetyeva E.V., Fursenko V.A. Obesity – threat to the reproductive potential of Russia. Obesity and metabolism. 2019;16(3):20-28. (In Russ.) doi: 10.14341/omet10340
  83. Kwong W, Tomlinson G, Feig DS. Maternal and neonatal outcomes after bariatric surgery; a systematic review and meta-analysis: do the benefits outweigh the risks? Am J Obstet Gynecol. 2018;218(6):573-580. doi: 10.1016/j.ajog.2018.02.003.
  84. Andreeva E.N., Absatarova Yu.S., Sheremetyeva E.V., Fursenko V.A. Obesity and reproductive function of women: epigenetic and somato-psychological features. Obesity and metabolism. 2019;16(2):9-15. (In Russ.). doi: 10.14341/omet10113
  85. Guardado-Mendoza R, Salazar-López SS, Álvarez-Canales M, et al. The combination of linagliptin, metformin and lifestyle modification to prevent type 2 diabetes (PRELLIM). A randomized clinical trial. Metabolism. 2020;104:154054. doi: 10.1016/j.metabol.2019.154054
  86. Vitek WS, Hoeger KM. Worth the wait? Preconception weight reduction in women and men with obesity and infertility: a narrative review. Fertil Steril. 2022;118(3):447-455. doi: 10.1016/j.fertnstert.2022.07.001.
  87. Leskova I.V., Ershova E.V., Nikitina E.A., et al. Obesity in Russia: modern view in the light of a social problems. Obesity and metabolism. 2019;16(1):20-26. (In Russ.). doi: 10.14341/omet9988
  88. Hill B, Azzari Wynn-Jones A, Botting KJ, et al. The Challenge of Weight Stigma for Women in the Preconception Period: Workshop Recommendations for Action from the 5th European Conference on Preconception Health and Care. Int J Environ Res Public Health. 2023;20(22):7034. doi: 10.3390/ijerph20227034.
  89. Hill B, Incollingo Rodriguez AC. Weight Stigma across the Preconception, Pregnancy, and Postpartum Periods: A Narrative Review and Conceptual Model. Semin Reprod Med. 2020;38(6):414-422. doi: 10.1055/s-0041-1723775.
  90. Welsh S, Salazar-Collier C, Blakeslee B, et al. Comparison of obstetrician-gynecologists and family physicians regarding weight-related attitudes, communication, and bias. Obes Res Clin Pract. 2021;15(4):351-356. doi: 10.1016/j.orcp.2021.04.010.
  91. Lichtenstein AH, Appel LJ, Vadiveloo M, et al. 2021 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association. Circulation. 2021;144(23):e472-e487. doi: 10.1161/CIR.0000000000001031.
  92. Vitek WS, Hoeger KM. Worth the wait? Preconception weight reduction in women and men with obesity and infertility: a narrative review. Fertil Steril. 2022;118(3):447-455. doi: 10.1016/j.fertnstert.2022.07.001.Doi:.15829/1560-4071-2019-4-48-52
  93. Gascoigne EL, Webster CM, Honart AW, et al. Physical activity and pregnancy outcomes: an expert review. Am J Obstet Gynecol MFM. 2023;5(1):100758. doi: 10.1016/j.ajogmf.2022.100758.
  94. Nystoriak MA, Bhatnagar A. Cardiovascular Effects and Benefits of Exercise. Front Cardiovasc Med. 2018;5:135. doi: 10.3389/fcvm.2018.00135.
  95. Buck Louis GM, Sapra KJ, Schisterman EF, et al. Lifestyle and pregnancy loss in a contemporary cohort of women recruited before conception: The LIFE Study. Fertil Steril. 2016;106(1):180-188. doi: 10.1016/j.fertnstert.2016.03.009

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.